← Leaderboards
Charles Joel Arntzen
Arizona State University-Tempe Campus
$6,423,517
Attributed
$6,423,517
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.9M · FY2005–09$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$17,217,186 · 6
By mechanism
U19$13,974,733 · 4
U01$2,876,373 · 1
S10$366,080 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesTransgenic PlantsPlantsGenesAntibodiesProteinsProductionLinkImmunogenicYeastsPropertyAntigensTobaccoMonoclonal AntibodyBaseBacteriaImmunizationMediatingExpression VectorImmune ResponseInvestmentsCorn Of ToeCostImmunologic Substance Development /Preparation
Grant awards (25)
Plant-derived vaccines against hepatitis C Cooperative *$735,946
U19 · FY2009 · AI · contact PI
Plant-Based Production of Non-Envelope Antigens of HCV$273,725
U19 · FY2009 · AI · contact PI
Plant-Made Microbicides and Mucosal Vaccines for STIs$1,264,061
U19 · FY2008 · AI · contact PI
Development of a vaccine for Ebola virus in plant system$757,135
U01 · FY2008 · AI · contact PI
Plant-derived vaccines against hepatitis C Cooperative *$714,512
U19 · FY2008 · AI · contact PI
Core--Production Facility$336,364
U19 · FY2008 · AI · contact PI
Plant-Based Production of Non-Envelope Antigens of HCV$272,474
U19 · FY2008 · AI · contact PI
Plant-Made Microbicides and Mucosal Vaccines for STIs$1,423,958
U19 · FY2007 · AI · contact PI
Development of a vaccine for Ebola virus in plant system$777,770
U01 · FY2007 · AI · contact PI
Plant-derived vaccines against hepatitis C Cooperative *$707,140
U19 · FY2007 · AI · contact PI
Core--Production Facility$378,916
U19 · FY2007 · AI · contact PI
Biacore T100$366,080
S10 · FY2007 · RR · contact PI
Plant-Based Production of Non-Envelope Antigens of HCV$238,474
U19 · FY2007 · AI · contact PI
Plant-Made Microbicides and Mucosal Vaccines for STIs$1,491,356
U19 · FY2006 · AI · contact PI
Development of a vaccine for Ebola virus in plant system$765,070
U01 · FY2006 · AI · contact PI
Plant-derived vaccines against hepatitis C Cooperative *$704,052
U19 · FY2006 · AI · contact PI
Production Core$406,399
U19 · FY2006 · AI · contact PI
Plant-Based Production of Non-Envelope Antigens of HCV$238,761
U19 · FY2006 · AI · contact PI
Plant-Made Microbicides and Mucosal Vaccines for STIs$1,515,292
U19 · FY2005 · AI
Plant-derived vaccines against hepatitis C Cooperative *$700,000
U19 · FY2005 · AI
Development of a vaccine for Ebola virus in plant system$576,398
U01 · FY2005 · AI
Production Core$403,219
U19 · FY2005 · AI
Plant-Based Production of Non-Envelope Antigens of HCV$223,643
U19 · FY2005 · AI
Plant-Made Microbicides and Mucosal Vaccines for STIs$1,537,352
U19 · FY2004 · AI
Production Core$409,089
U19 · FY2004 · AI